- Trials with a EudraCT protocol (19)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
19 result(s) found for: Antidote.
Displaying page 1 of 1.
EudraCT Number: 2011-000206-22 | Sponsor Protocol Number: 130101 | Start Date*: 2011-04-11 |
Sponsor Name:Helsingin Yliopisto, Kemian laitos | ||
Full Title: Elimination kinetics of HCN after inhaled exposure | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001151-40 | Sponsor Protocol Number: CTU148N | Start Date*: 2019-07-09 |
Sponsor Name:RIEMSER Pharma GmbH | ||
Full Title: Phase II pilot study: To determine an effective and tolerable dose of Hylase® "Dessau" (bovine hyaluronidase) in the treatment of hyaluronic acid filler overshoots by injection into defined areas o... | ||
Medical condition: In this study, healthy subjects get an artificial over-injection with Hyaluron acid filler on the back of the hands. To demonstrate the effectiveness of hylase® "Dessau" as an antidote for hyaluro... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-000379-96 | Sponsor Protocol Number: INnaloxonePed-1 | Start Date*: 2017-05-05 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Pharmacokinetic and pharmacodynamic aspects in children after intranasal administration of the opioid antagonist naloxone | ||
Medical condition: Pharmacokinetic profile after nasal naloxone administration in Children. In second part study reversal of sedation after opioid use | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005663-27 | Sponsor Protocol Number: HDNX | Start Date*: 2013-02-27 | |||||||||||
Sponsor Name:HOC, Rigshospitalet | |||||||||||||
Full Title: Effect of a late naloxone-infusion on secondary hyperalgesia after a first degree heat injury. | |||||||||||||
Medical condition: First degree burn injury in healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005201-31 | Sponsor Protocol Number: INNalox-1 | Start Date*: 2015-03-31 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Pharmacokinetic profile and pharmacodynamic effects after intranasal naloxone administration in volunteers and pediatric patients. | ||
Medical condition: Sedation after opioid administration Pharmacokinetic profile after naloxone administered intranasally | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18, Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-001559-20 | Sponsor Protocol Number: 95195608 | Start Date*: 2007-04-17 |
Sponsor Name:Cliniques Universitaires Saint-Luc | ||
Full Title: Steady-state pharmacokinetics of high dose acetaminophen inpost-op children. Rational use of N-acetyl cysteine for prevention of liver toxicity related to cumulative doses. | ||
Medical condition: Major surgery when the use of paracetamol is required for pain release | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-000374-21 | Sponsor Protocol Number: 19-515 | Start Date*: 2020-08-17 | |||||||||||
Sponsor Name:Alexion Pharmaceuticals, Inc | |||||||||||||
Full Title: PROSPECTIVE, OPEN-LABEL STUDY OF ANDEXANET ALFA IN PATIENTS RECEIVING A FACTOR XA INHIBITOR WHO REQUIRE URGENT SURGERY (ANNEXA-S) | |||||||||||||
Medical condition: Need for FXa inhibitor reversal in patients undergoing urgent surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002620-17 | Sponsor Protocol Number: 18-513 | Start Date*: 2019-01-08 | |||||||||||
Sponsor Name:Portola Pharmaceuticals, Inc | |||||||||||||
Full Title: A PHASE 4 RANDOMIZED CLINICAL TRIAL OF ANDEXANET ALFA [ANDEXANET ALFA FOR INJECTION] IN ACUTE INTRACRANIAL HEMORRHAGE IN PATIENTS RECEIVING AN ORAL FACTOR XA INHIBITOR | |||||||||||||
Medical condition: Oral FXa inhibitor-treated patients with acute intracranial bleeding. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) GB (GB - no longer in EU/EEA) AT (Completed) BE (Completed) NL (Completed) ES (Prematurely Ended) GR (Completed) CZ (Completed) LV (Completed) FI (Prematurely Ended) NO (Prematurely Ended) LT (Prematurely Ended) PL (Completed) PT (Prematurely Ended) DK (Prematurely Ended) IT (Prematurely Ended) HU (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003220-36 | Sponsor Protocol Number: 45112 | Start Date*: 2014-05-21 |
Sponsor Name:Albert Schweitzer hospital | ||
Full Title: Remifentanil use for procedural sedation and analgesia in the emergency department | ||
Medical condition: The research will be conducted in patients that need short painfull treatment in the emergency department and with an indication for PSA. These treatments include: repositioning of fractures, repos... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000815-42 | Sponsor Protocol Number: HighNxGHR_PK | Start Date*: 2015-04-28 | |||||||||||
Sponsor Name:Rigshospitalet, Copenhagen University Hospitals | |||||||||||||
Full Title: Pharmacokinetics of High-dose Target-controlled Naloxone Infusion. Companion study to: Effect of High-dose Target-controlled Naloxone Infusion on Pain and Hyperalgesia in Patients following Groin-H... | |||||||||||||
Medical condition: Healthy subjects | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004072-22 | Sponsor Protocol Number: NINA-1 | Start Date*: 2017-12-07 | |||||||||||||||||||||||||||||||
Sponsor Name:Norwegian University of Science and Technology (NTNU) | |||||||||||||||||||||||||||||||||
Full Title: NTNU Intranasal Naloxone Trial Double blinded, double dummy, randomised controlled trial of intranasal naloxone for pre hospital use | |||||||||||||||||||||||||||||||||
Medical condition: We investigate the reversal of opioid overdoses in the pre hospital setting | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: NO (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-000013-20 | Sponsor Protocol Number: 2018-000013-20 | Start Date*: 2018-05-07 |
Sponsor Name:KU Leuven | ||
Full Title: Placebo-controlled crossover study of the ability of Naloxegol to reverse opioid effect on colonic motor patterns in healthy volunteers | ||
Medical condition: This study will be performed in healthy volunteers. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001785-26 | Sponsor Protocol Number: 14-505 | Start Date*: 2016-02-15 | |||||||||||
Sponsor Name:Portola Pharmaceuticals, Inc. | |||||||||||||
Full Title: Prospective, Open-label Study of Andexanet Alfa in Patients Receiving a Factor Xa Inhibitor who Have Acute Major Bleeding (ANNEXA-4). | |||||||||||||
Medical condition: Uncontrolled bleeding in patients who have taken either a direct factor Xa inhibitor (novel oral anticoagulants) or an indirect factor Xa inhibitor (low molecular weight heparins). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) GB (Completed) BE (Completed) DE (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004706-14 | Sponsor Protocol Number: MT201-204 | Start Date*: 2009-02-09 |
Sponsor Name:Micromet AG | ||
Full Title: A randomized, open-label, controlled, multi-center Phase II study to evaluate the efficacy and safety of adecatumumab alone or sequentially to FOLFOX relative to FOLFOX after R0 resection of colore... | ||
Medical condition: R0 resected liver metastases from colorectal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-000246-21 | Sponsor Protocol Number: PP100-001 | Start Date*: 2017-04-25 | |||||||||||
Sponsor Name:PledPharma AB | |||||||||||||
Full Title: A Randomised Open Label Exploratory, Safety and Tolerability Study with PP100-01 in Patients Treated with the 12-hour Regimen of N-Acetylcysteine for Paracetamol/Acetaminophen Overdose | |||||||||||||
Medical condition: The objective of this study is to develop a therapeutic regimen for paracetamol/acetaminophen overdose (POD) where a novel NAC 12hr regime is combined with a superoxide dismutase (SOD) mimetic, PP1... | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000793-36 | Sponsor Protocol Number: HighNxGHR | Start Date*: 2015-04-28 | |||||||||||
Sponsor Name:Rigshospitalet, Copenhagen University Hospitals | |||||||||||||
Full Title: Effect of High-dose Target-controlled Naloxone Infusion on Pain and Hyperalgesia in Patients following Groin-Hernia-Repair. A companion study to: Pharmacokinetics of High-dose Target-controlled Nal... | |||||||||||||
Medical condition: Groin hernia repair | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001857-22 | Sponsor Protocol Number: Methadone-010922 | Start Date*: 2022-09-06 | |||||||||||||||||||||||||||||||
Sponsor Name:Sygehus Sønderjylland, Orthopedic department | |||||||||||||||||||||||||||||||||
Full Title: Perioperative Methadone for ameliorating postoperative pain and reduction in postoperative opioid consumption in hip fracture patients – Dosage adjusting pilot-study | |||||||||||||||||||||||||||||||||
Medical condition: Hip fractures | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004898-41 | Sponsor Protocol Number: NBK241/1/2020 | Start Date*: 2021-03-31 | |||||||||||
Sponsor Name:MEDICAL UNIVERSITY OF GDAŃSK | |||||||||||||
Full Title: A multicentre, parallel group, randomised, double blind, placebo-controlled, phase II study evaluating the efficacy and safety of reperfusion thrombolytic therapy with intravenous recombinant tissu... | |||||||||||||
Medical condition: Acute ischemic stroke | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005426-19 | Sponsor Protocol Number: 51237 | Start Date*: 2016-02-09 | |||||||||||
Sponsor Name:Rigshospitalet, Copenhagen University Hospitals | |||||||||||||
Full Title: "Effect of High-dose Target-controlled Naloxone Infusion on Pain and Hyperalgesia in Patients following Recovery from Impacted Mandibular Third Molar Extraction. A Randomized, Placebo-controlled, ... | |||||||||||||
Medical condition: Healthy volunteers (n = 94) are included. The main study includes 14 subjects who have had an uncomplicated, impacted mandibular, third molar extraction 4-5 weeks prior to participation in the stud... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.